Skip to main content
Top
Published in: Gastric Cancer 3/2013

01-07-2013 | Original Article

Pattern of abdominal nodal spread and optimal abdominal lymphadenectomy for advanced Siewert type II adenocarcinoma of the cardia: results of a multicenter study

Authors: Kazumasa Fujitani, Isao Miyashiro, Shoki Mikata, Shigeyuki Tamura, Hiroshi Imamura, Johji Hara, Yukinori Kurokawa, Jyunya Fujita, Kazuhiro Nishikawa, Yutaka Kimura, Shuji Takiguchi, Masaki Mori, Yuichiro Doki

Published in: Gastric Cancer | Issue 3/2013

Login to get access

Abstract

Background

It remains uncertain whether radical lymphadenectomy combined with total gastrectomy actually contributes to long-term survival for Siewert type II adenocarcinoma of the cardia. We identified the pattern of abdominal nodal spread in advanced type II adenocarcinoma and defined the optimal extent of abdominal lymphadenectomy.

Methods

Eighty-six patients undergoing R0 total gastrectomy for advanced type II adenocarcinoma were identified from the gastric cancer database of 4,884 patients. Prognostic factors were investigated by multivariate analysis. The therapeutic value of lymph node dissection for each station was estimated by multiplying the incidence of metastasis by the 5-year survival rate of patients with positive nodes in each station.

Results

The overall 5-year survival rate was 37.1 %. Age less than 65 years [hazard ratio, 0.455 (95 % confidence interval (CI), 0.261–0.793)] and nodal involvement with pN3 as referent [hazard ratio for pN0, 0.129 (95 % CI, 0.048–0.344); for pN1, 0.209 (95 % CI, 0.097–0.448); and for pN2, 0.376 (95 % CI, 0.189–0.746)] were identified as significant prognosticators for longer survival. Perigastric nodes of the lower half of the stomach in positions 4d–6 were considered not beneficial to dissect, whereas there were substantial therapeutic benefits to dissecting the perigastric nodes of the upper half of the stomach in positions 1–3 and the second-tier nodes in positions 7 and 11.

Conclusions

Limited lymphadenectomy attained by proximal gastrectomy might suffice as an alternative to extended lymphadenectomy with total gastrectomy for obtaining potential therapeutic benefit in abdominal lymphadenectomy for advanced Siewert type II adenocarcinoma.
Literature
1.
go back to reference Wu H, Rusiecki JA, Zhu K, Potter J, Devesa SS. Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol Biomark Prev. 2009;18:1945–52.CrossRef Wu H, Rusiecki JA, Zhu K, Potter J, Devesa SS. Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol Biomark Prev. 2009;18:1945–52.CrossRef
2.
go back to reference Steevens J, Botterweck AA, Dirx MJ, van den Brandt PA, Schouten LJ. Trends in incidence of oesophageal and stomach cancer subtypes in Europe. Eur J Gastroenterol Hepatol. 2010;22:669–78.PubMed Steevens J, Botterweck AA, Dirx MJ, van den Brandt PA, Schouten LJ. Trends in incidence of oesophageal and stomach cancer subtypes in Europe. Eur J Gastroenterol Hepatol. 2010;22:669–78.PubMed
3.
go back to reference Siewert JR, Stein HJ. Carcinoma of the cardia: carcinoma of the gastroesophageal junction—classification, pathology and extent of resection. Dis Esophagus. 1996;9:173–82. Siewert JR, Stein HJ. Carcinoma of the cardia: carcinoma of the gastroesophageal junction—classification, pathology and extent of resection. Dis Esophagus. 1996;9:173–82.
4.
go back to reference Siewert JR, Feith M, Stein HJ. Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification. J Surg Oncol. 2005;90:139–46.PubMedCrossRef Siewert JR, Feith M, Stein HJ. Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification. J Surg Oncol. 2005;90:139–46.PubMedCrossRef
5.
go back to reference Feith M, Stein HJ, Siewert JR. Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients. Surg Oncol Clin N Am. 2006;15:751–64.PubMedCrossRef Feith M, Stein HJ, Siewert JR. Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients. Surg Oncol Clin N Am. 2006;15:751–64.PubMedCrossRef
6.
go back to reference Kodera Y, Yamamura Y, Shimizu Y, Torii A, Hirai T, Yasui K, et al. Adenocarcinoma of the gastroesophageal junction in Japan: relevance of Siewert’s classification applied to 177 cases resected at a single institution. J Am Coll Surg. 1999;189:594–601.PubMedCrossRef Kodera Y, Yamamura Y, Shimizu Y, Torii A, Hirai T, Yasui K, et al. Adenocarcinoma of the gastroesophageal junction in Japan: relevance of Siewert’s classification applied to 177 cases resected at a single institution. J Am Coll Surg. 1999;189:594–601.PubMedCrossRef
7.
go back to reference Kusano C, Gotoda T, Khor CJ, Katai H, Kato H, Taniguchi H, et al. Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan. J Gastroenterol Hepatol. 2008;23:1662–5.PubMedCrossRef Kusano C, Gotoda T, Khor CJ, Katai H, Kato H, Taniguchi H, et al. Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan. J Gastroenterol Hepatol. 2008;23:1662–5.PubMedCrossRef
8.
go back to reference Chung JW, Lee GH, Choi KS, Kim DH, Jung KW, Song HJ, et al. Unchanging trend of esophagogastric junction adenocarcinoma in Korea: experience at a single institution based on Siewert’s classification. Dis Esophagus. 2009;22:676–81.PubMedCrossRef Chung JW, Lee GH, Choi KS, Kim DH, Jung KW, Song HJ, et al. Unchanging trend of esophagogastric junction adenocarcinoma in Korea: experience at a single institution based on Siewert’s classification. Dis Esophagus. 2009;22:676–81.PubMedCrossRef
9.
go back to reference Fang WL, Wu CW, Chen JH, Lo SS, Hsieh MC, Shen KH, et al. Esophagogastric junction adenocarcinoma according to Siewert classification in Taiwan. Ann Surg Oncol. 2009;16:3237–44.PubMedCrossRef Fang WL, Wu CW, Chen JH, Lo SS, Hsieh MC, Shen KH, et al. Esophagogastric junction adenocarcinoma according to Siewert classification in Taiwan. Ann Surg Oncol. 2009;16:3237–44.PubMedCrossRef
10.
go back to reference Steup WH, De Leyn P, Deneffe G, van Raemdonck D, Coosemans W. Tumors of the esophagogastric junction. Long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification. J Thorac Cardiovasc Surg. 1996;111:85–94.PubMedCrossRef Steup WH, De Leyn P, Deneffe G, van Raemdonck D, Coosemans W. Tumors of the esophagogastric junction. Long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification. J Thorac Cardiovasc Surg. 1996;111:85–94.PubMedCrossRef
11.
go back to reference Sasako M, Sano T, Yamamoto S, Sairenji M, Arai K, Kinoshita T, et al. Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol. 2006;7:644–51.PubMedCrossRef Sasako M, Sano T, Yamamoto S, Sairenji M, Arai K, Kinoshita T, et al. Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol. 2006;7:644–51.PubMedCrossRef
12.
go back to reference Omloo JM, Lagarde SM, Hulscher JB, Reitsma JB, Fockens P, van Dekken H, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg. 2007;246:992–1000.PubMedCrossRef Omloo JM, Lagarde SM, Hulscher JB, Reitsma JB, Fockens P, van Dekken H, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg. 2007;246:992–1000.PubMedCrossRef
13.
go back to reference Stipa F, Ferri M, Aromatario C, Stipa S. Carcinoma of the cardia: is there a place for proximal gastric resection in cancer of the cardia? Dis Esophagus. 1996;9:183–6. Stipa F, Ferri M, Aromatario C, Stipa S. Carcinoma of the cardia: is there a place for proximal gastric resection in cancer of the cardia? Dis Esophagus. 1996;9:183–6.
14.
go back to reference Sobin LH, Gospodarowicz MK, Wittekind CH. TNM classification of malignant tumours. 7th ed. Oxford: Wiley-Blackwell; 2009. Sobin LH, Gospodarowicz MK, Wittekind CH. TNM classification of malignant tumours. 7th ed. Oxford: Wiley-Blackwell; 2009.
15.
go back to reference Japanese classification of gastric carcinoma: 2nd English edition. Gastric Cancer 1998;1:10–24. Japanese classification of gastric carcinoma: 2nd English edition. Gastric Cancer 1998;1:10–24.
16.
go back to reference Sasako M, McCulloch P, Kinoshita T, Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg. 1995;82:346–51.PubMedCrossRef Sasako M, McCulloch P, Kinoshita T, Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg. 1995;82:346–51.PubMedCrossRef
17.
go back to reference de Manzoni G, Morgagni P, Roviello F, Di Leo A, Saragoni L, Marrelli D, et al. Nodal abdominal spread in adenocarcinoma of the cardia. Results of a multicenter prospective study. Gastric Cancer. 1998;1:146–51.PubMedCrossRef de Manzoni G, Morgagni P, Roviello F, Di Leo A, Saragoni L, Marrelli D, et al. Nodal abdominal spread in adenocarcinoma of the cardia. Results of a multicenter prospective study. Gastric Cancer. 1998;1:146–51.PubMedCrossRef
18.
go back to reference Pedrazzani C, de Manzoni G, Marrelli D, Giacopuzzi S, Corso G, Minicozzi AM, et al. Lymph node involvement in advanced gastroesophageal junction adenocarcinoma. J Thorac Cardiovasc Surg. 2007;134:378–85.PubMedCrossRef Pedrazzani C, de Manzoni G, Marrelli D, Giacopuzzi S, Corso G, Minicozzi AM, et al. Lymph node involvement in advanced gastroesophageal junction adenocarcinoma. J Thorac Cardiovasc Surg. 2007;134:378–85.PubMedCrossRef
19.
go back to reference Yamashita H, Katai H, Morita S, Saka M, Taniguchi H, Fukagawa T. Optimal extent of lymph node dissection for Siewert type II esophagogastric junction carcinoma. Ann Surg. 2011;254:274–80.PubMedCrossRef Yamashita H, Katai H, Morita S, Saka M, Taniguchi H, Fukagawa T. Optimal extent of lymph node dissection for Siewert type II esophagogastric junction carcinoma. Ann Surg. 2011;254:274–80.PubMedCrossRef
20.
go back to reference Hosokawa Y, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kato Y, et al. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan. Ann Surg Oncol. 2012;19:677–83.PubMedCrossRef Hosokawa Y, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kato Y, et al. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan. Ann Surg Oncol. 2012;19:677–83.PubMedCrossRef
21.
go back to reference Dresner SM, Lamb PJ, Bennett MK, Hayes N, Griffin SM. The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction. Surgery (St. Louis). 2001;129:103–9.CrossRef Dresner SM, Lamb PJ, Bennett MK, Hayes N, Griffin SM. The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction. Surgery (St. Louis). 2001;129:103–9.CrossRef
22.
go back to reference Yuasa N, Miyake H, Yamada T, Ebata T, Nimura Y, Hattori T. Clinicopathologic comparison of Siewert type II and III adenocarcinomas of the gastroesophageal junction. World J Surg. 2006;30:364–71.PubMedCrossRef Yuasa N, Miyake H, Yamada T, Ebata T, Nimura Y, Hattori T. Clinicopathologic comparison of Siewert type II and III adenocarcinomas of the gastroesophageal junction. World J Surg. 2006;30:364–71.PubMedCrossRef
23.
go back to reference Lagarde SM, Cense HA, Hulscher JB, Tilanus HW, Ten Kate FJ, Obertop H, et al. Prospective analysis of patients with adenocarcinoma of the gastric cardia and lymph node metastasis in the proximal field of the chest. Br J Surg. 2005;92:1404–8.PubMedCrossRef Lagarde SM, Cense HA, Hulscher JB, Tilanus HW, Ten Kate FJ, Obertop H, et al. Prospective analysis of patients with adenocarcinoma of the gastric cardia and lymph node metastasis in the proximal field of the chest. Br J Surg. 2005;92:1404–8.PubMedCrossRef
24.
go back to reference Wayman J, Bennett MK, Raimes SA, Griffin SM. The pattern of recurrence of adenocarcinoma of the esophago-gastric junction. Br J Cancer. 2002;86:1223–9.PubMedCrossRef Wayman J, Bennett MK, Raimes SA, Griffin SM. The pattern of recurrence of adenocarcinoma of the esophago-gastric junction. Br J Cancer. 2002;86:1223–9.PubMedCrossRef
25.
go back to reference Sano T, Yamamoto S, Japan Clinical Oncology Group Study JCOG 0110-MF. Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma: Japan Clinical Oncology Group study JCOG 0110-MF. Jpn J Clin Oncol. 2002;32:363–4.PubMedCrossRef Sano T, Yamamoto S, Japan Clinical Oncology Group Study JCOG 0110-MF. Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma: Japan Clinical Oncology Group study JCOG 0110-MF. Jpn J Clin Oncol. 2002;32:363–4.PubMedCrossRef
26.
go back to reference Stein HJ, Feith M, Mueller J, Werner M, Siewert JR. Limited resection for early adenocarcinoma in Barrett’s esophagus. Ann Surg. 2000;232:733–42.PubMedCrossRef Stein HJ, Feith M, Mueller J, Werner M, Siewert JR. Limited resection for early adenocarcinoma in Barrett’s esophagus. Ann Surg. 2000;232:733–42.PubMedCrossRef
27.
go back to reference Jakl RJ, Miholic J, Koller R, Markis E, Wolner E. Prognostic factors in adenocarcinoma of the cardia. Am J Surg. 1995;169:316–9.PubMedCrossRef Jakl RJ, Miholic J, Koller R, Markis E, Wolner E. Prognostic factors in adenocarcinoma of the cardia. Am J Surg. 1995;169:316–9.PubMedCrossRef
28.
go back to reference Harrison LE, Karpeh MS, Brennan MF. Total gastrectomy is not necessary for proximal gastric cancer. Surgery (St. Louis). 1998;123:127–30.CrossRef Harrison LE, Karpeh MS, Brennan MF. Total gastrectomy is not necessary for proximal gastric cancer. Surgery (St. Louis). 1998;123:127–30.CrossRef
29.
go back to reference Papachristou DN, Fortner JG. Adenocarcinoma of the gastric cardia: the choice of gastrectomy. Ann Surg. 1980;192:58–64.PubMedCrossRef Papachristou DN, Fortner JG. Adenocarcinoma of the gastric cardia: the choice of gastrectomy. Ann Surg. 1980;192:58–64.PubMedCrossRef
30.
go back to reference Moreaux J, Msika S. Carcinoma of the gastric cardia: surgical management and long-term survival. World J Surg. 1988;12:229–35.PubMedCrossRef Moreaux J, Msika S. Carcinoma of the gastric cardia: surgical management and long-term survival. World J Surg. 1988;12:229–35.PubMedCrossRef
31.
go back to reference Graham D, Zucker E, Ishmil N, Coit D, Brennan M. Prospective assessment of short-term quality of life after total, distal or proximal gastrectomy for gastric cancer. J Clin Oncol. 2007;25(18S):abstr 15020. Graham D, Zucker E, Ishmil N, Coit D, Brennan M. Prospective assessment of short-term quality of life after total, distal or proximal gastrectomy for gastric cancer. J Clin Oncol. 2007;25(18S):abstr 15020.
Metadata
Title
Pattern of abdominal nodal spread and optimal abdominal lymphadenectomy for advanced Siewert type II adenocarcinoma of the cardia: results of a multicenter study
Authors
Kazumasa Fujitani
Isao Miyashiro
Shoki Mikata
Shigeyuki Tamura
Hiroshi Imamura
Johji Hara
Yukinori Kurokawa
Jyunya Fujita
Kazuhiro Nishikawa
Yutaka Kimura
Shuji Takiguchi
Masaki Mori
Yuichiro Doki
Publication date
01-07-2013
Publisher
Springer Japan
Published in
Gastric Cancer / Issue 3/2013
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-012-0183-0

Other articles of this Issue 3/2013

Gastric Cancer 3/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.